Nanoparticles containing β‐cyclodextrin potentially useful for the treatment of Niemann‐Pick C

β‐Cyclodextrin (β‐CD) is being considered a promising therapy for Niemann‐Pick C (NPC) disease because of its ability to mobilise the entrapped cholesterol from lysosomes, however, a major limitation is its inability to cross the blood‐brain barrier (BBB) and address the central nervous system (CNS)...

Ausführliche Beschreibung